Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-23

Clinical Trial Update: Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ACU-D1 for acne rosacea has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACU-D1

Snippet

Sponsor: Accuitis, Inc. | Conditions: Acne Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2021-08-23